Exhibit 23.1

           Consent of Independent Registered Public Accounting Firm
           --------------------------------------------------------


The Board of Directors
K-V Pharmaceutical Company:

We consent to the incorporation by reference in the registration statements
(Nos. 2-56793, 2-76173, 33-46400, 33-44927, 333-00199, 333-48252 and
333-85516) on Form S-8 and registration statements (Nos. 333-87402 and
333-106294) on Form S-3 of our reports dated March 25, 2008, with respect to
the consolidated balance sheets of K-V Pharmaceutical Company and subsidiaries
(the Company) as of March 31, 2007 and 2006, the related consolidated
statements of income, comprehensive income, shareholders' equity, and cash
flows for each of the years in the three-year period ended March 31, 2007, and
the related financial statement schedule for the years then ended,
management's assessment of the effectiveness of internal control over
financial reporting as of March 31, 2007 and the effectiveness of internal
control over financial reporting as of March 31, 2007, which reports appear in
the March 31, 2007 annual report on Form 10-K of K-V Pharmaceutical Company.

Our report dated March 25, 2008 on the consolidated financial statements
refers to the Company's adoption of the provisions of Statement of Financial
Accounting Standards No. 123 (Revised 2004), "Share-Based Payment", effective
April 1, 2006.

Our report dated March 25, 2008 on the consolidated financial statements
states that the Company's consolidated balance sheet as of March 31, 2006, and
the related consolidated statements of income, comprehensive income,
shareholders' equity, and cash flows for the years ended March 31, 2006 and
2005, have been restated.

Our report dated March 25, 2008 on management's assessment of the
effectiveness of internal control over financial reporting and the
effectiveness of internal control over financial reporting as of March 31,
2007 expresses our opinion that the Company did not maintain effective
internal control over financial reporting as of March 31, 2007 because of the
effect of material weaknesses on the achievement of the objectives of the
control criteria and contains an explanatory paragraph that states that the
existence of a number of material weaknesses resulted in more than a remote
likelihood that a material misstatement of the Company's annual or interim
financial statements would not be prevented or detected in various account
balances.



KPMG, LLP
St. Louis, Missouri
March 25, 2008

                                     174